The 5-Minute Guide to Horizon Pharma PLC Stock – The Motley Fool #valeant #pharma

Posted On Jan 7 2018 by

#horizon pharma # The 5-Minute Guide to Horizon Pharma PLC Stock Value investors don’t need to know a mitochondria from a hole in the ground to sense something’s amiss with Horizon Pharmaceuticals (NASDAQ:HZNP ) stock. Over the past several years the company’s sales have exploded, yet the stock fallen roughly 50% from its peak last summer. With a forward price-to-earnings ratio under 10, this looks like a bargain hunter’s dream come true. Before you go diving in, take five minutes to familiarize yourself with this company. You’ll be glad you did. Pharma-funds Even if you don’t follow pharmaceutical industry news, …


Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #global #pharmaceutical #industry

Posted On Jan 7 2018 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


Horizon Pharma Bids $3 Billion For Depomed #mcneil #pharma

Posted On Dec 8 2017 by

#horizon pharma # Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival Ireland s Horizon Pharma is bringing its $3 billion takeover offer for U.S. rival Depomed directly to the company s shareholders after being rebuffed in its attempts to negotiate with Depomed s management. Horizon s HZNP hostile bid for Depomed DEPO . announced on Tuesday. values the Newark, Calif.-based specialty pharmaceutical company at $29.25 per share, which represents a 42% premium over Depomed s Monday closing price. Depomed s share price jumped nearly 40% on the news of Horizon s offer. The Irish manufacturer of drugs …


Horizon Pharma slapped with securities lawsuit over patient assistance programs #gmp #pharma

Posted On Nov 29 2017 by

#horizon pharma # Horizon Pharma slapped with securities lawsuit over patient assistance programs Horizon Pharma ($HZNP) has already come under fire from federal prosecutors and payers for its patient assistance programs and questionable ties to specialty pharmacies. Now the company is being slapped with the inevitable securities lawsuit in a U.S. district court over related allegations. New York-based law firm Gainey McKenna Egleston filed a suit in the U.S. District Court for the Southern District of New York on behalf of people who bought stock in Horizon between March 13, 2014, and Feb. 26, 2016. The firm claims that Horizon …


Horizon Pharma Bids $3 Billion For Depomed #abbott #pharma

Posted On Nov 29 2017 by

#horizon pharma # Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival Ireland s Horizon Pharma is bringing its $3 billion takeover offer for U.S. rival Depomed directly to the company s shareholders after being rebuffed in its attempts to negotiate with Depomed s management. Horizon s HZNP hostile bid for Depomed DEPO . announced on Tuesday. values the Newark, Calif.-based specialty pharmaceutical company at $29.25 per share, which represents a 42% premium over Depomed s Monday closing price. Depomed s share price jumped nearly 40% on the news of Horizon s offer. The Irish manufacturer of drugs …


Blow fill Seal Horizon Pharmaceuticals packaging BFS aseptic steril bottles #pharma #technology

Posted On Nov 13 2017 by

#horizon pharma # Horizon Pharmaceuticals, Inc. Horizon Pharmaceuticals, Inc. is a company focused on the development, manufacture and life cycle management of Blow-Fill-Seal (BFS) tech no logy and products for the pharmaceutical, medical device, diagnostic and clinical industries. Horizon is an independent pharmaceutical company uniquely positioned in the industry to fulfill Blow-Fill-Seal product development needs. Horizon has the capabilities to complete projects from any stage of the development cycle. Horizon operates two segments, Blow-Fill-Seal drug discovery and development, and Blow-Fill-Seal manufacturing, including in-house mold fabrication. Horizon Pharmaceutical, Inc. Aseptic BFS Pharmaceutical Manufacturing Palm Beach County, FL For Business development please …


Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #contract #manufacturing #pharma

Posted On Sep 30 2017 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


The 5-Minute Guide to Horizon Pharma PLC Stock – The Motley Fool #aton #pharma

Posted On Sep 30 2017 by

#horizon pharma # The 5-Minute Guide to Horizon Pharma PLC Stock Value investors don’t need to know a mitochondria from a hole in the ground to sense something’s amiss with Horizon Pharmaceuticals (NASDAQ:HZNP ) stock. Over the past several years the company’s sales have exploded, yet the stock fallen roughly 50% from its peak last summer. With a forward price-to-earnings ratio under 10, this looks like a bargain hunter’s dream come true. Before you go diving in, take five minutes to familiarize yourself with this company. You’ll be glad you did. Pharma-funds Even if you don’t follow pharmaceutical industry news, …


Blow fill Seal Horizon Pharmaceuticals packaging BFS aseptic steril bottles #tranzyme #pharma

Posted On Sep 6 2017 by

#horizon pharma # Horizon Pharmaceuticals, Inc. Horizon Pharmaceuticals, Inc. is a company focused on the development, manufacture and life cycle management of Blow-Fill-Seal (BFS) tech no logy and products for the pharmaceutical, medical device, diagnostic and clinical industries. Horizon is an independent pharmaceutical company uniquely positioned in the industry to fulfill Blow-Fill-Seal product development needs. Horizon has the capabilities to complete projects from any stage of the development cycle. Horizon operates two segments, Blow-Fill-Seal drug discovery and development, and Blow-Fill-Seal manufacturing, including in-house mold fabrication. Horizon Pharmaceutical, Inc. Aseptic BFS Pharmaceutical Manufacturing Palm Beach County, FL For Business development please …


Horizon Pharma Raises CEO Walbert – s Pay 10-Fold to $93 #global #pharm

Posted On Aug 25 2017 by

#horizon pharma # Horizon Pharma Raises CEO Walbert’s Pay 10-Fold to $93.4 Million Horizon Pharma Plc gave Chief Executive Officer Timothy Walbert a $93.4 million pay package for 2015, a 10-fold increase from the previous year as the company came under scrutiny for its distribution practices. Walbert received stock options valued at $47.4 million and $43.5 million in restricted shares, according to a preliminary proxy filed Tuesday. The options and about a quarter of the shares will vest over four years, with the remaining stock vesting in 2018 if the firm meets performance targets. His pay package for 2014 was …